DSGN
Design Therapeutics, Inc.
Key Financials
Operating Income
$-79467000
↓ 27.4%
Net Income
$-69792000
↓ 40.7%
Revenue
$0
NaN%
Total Assets
$226.2M
↓ 10.3%
EPS (Diluted)
$-1.22
↓ 38.6%
Total Liabilities
$13.7M
↑ 37.1%
Shareholders' Equity
$212.5M
↓ 12.2%
Cash & Equivalents
$16.9M
↓ 25.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DSGN |
| Company Name | Design Therapeutics, Inc. |
| CIK | 1807120 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-293-4900 |